Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Cash from Investing Activities (2017 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Cash from Investing Activities for 9 consecutive years, with $48.8 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 659.48% to $48.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$49.3 million through Dec 2025, up 83.53% year-over-year, with the annual reading at -$49.3 million for FY2025, 83.53% up from the prior year.
  • Cash from Investing Activities hit $48.8 million in Q4 2025 for Protagonist Therapeutics, up from -$58.6 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $57.3 million in Q3 2022 to a low of -$208.7 million in Q3 2024.
  • Historically, Cash from Investing Activities has averaged -$15.6 million across 5 years, with a median of -$270500.0 in 2022.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 1657.48% in 2023 and later soared 659.48% in 2025.
  • Year by year, Cash from Investing Activities stood at $27.9 million in 2021, then crashed by 85.88% to $3.9 million in 2022, then crashed by 1657.48% to -$61.3 million in 2023, then soared by 85.76% to -$8.7 million in 2024, then skyrocketed by 659.48% to $48.8 million in 2025.
  • Business Quant data shows Cash from Investing Activities for PTGX at $48.8 million in Q4 2025, -$58.6 million in Q3 2025, and $54.8 million in Q2 2025.